Trial Profile

Anti-inflammatory Therapy to Improve Outcomes in Patients With Chronic Pancreatitis Undergoing Total Pancreatectomy Islet Autotransplantation

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 27 Jun 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Etanercept (Primary) ; Alpha 1-antitrypsin
Indications Pancreas transplant rejection
Focus Therapeutic Use

Most Recent Events

24 Jun 2025 Status changed from active, no longer recruiting to completed.
10 Aug 2023 Planned End Date changed from 1 Jul 2026 to 1 May 2025.
01 Jan 2023 Primary endpoint (Maximal acute C-peptide response to glucose (ACRmax)) has been met, as per Results published in the Pancreatology.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com